tradingkey.logo

BRIEF-Incyte And Genesis Therapeutics Announce Strategic AI-Focused Research Collaboration

ReutersFeb 20, 2025 1:02 PM

- Incyte Corp INCY.O:

  • INCYTE AND GENESIS THERAPEUTICS ANNOUNCE STRATEGIC AI-FOCUSED RESEARCH COLLABORATION

  • INCYTE CORP - RECEIVES EXCLUSIVE RIGHTS TO DEVELOP AND COMMERCIALIZE COLLABORATION PRODUCTS

  • INCYTE CORP - UNDER AGREEMENT, GENESIS TO RECEIVE $30 MILLION UPFRONT PAYMENT

  • INCYTE CORP - UNDER AGREEMENT, GENESIS ELIGIBLE FOR UP TO $295 MILLION IN MILESTONE PAYMENTS PER TARGET

  • INCYTE CORP - GENESIS ELIGIBLE FOR TIERED ROYALTIES ON SALES OF APPROVED PRODUCTS

Source text: ID:nBw96ftdza

Further company coverage: INCY.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI